Press release
Acne Market on Track for Major Expansion by 2032, According to DelveInsight | Clinuvel Pharma, Novan, Dermata Therapeutics, ioPharmX, Bausch Health Americas, Inc., Kintor Pharma, Sol-Gel Technologies
DelveInsight's "Acne Market Insights, Epidemiology, and Market Forecast-2032 report offers an in-depth understanding of the Acne, historical and forecasted epidemiology as well as the Acne market trends in the United States, EU4 (Germany, Spain, Italy, France) the United Kingdom and Japan.
To Know in detail about the Acne market outlook, drug uptake, treatment scenario and epidemiology trends, Click here; Acne Market Forecast [https://www.delveinsight.com/sample-request/acne-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=gpr]
Some of the key facts of the Acne Market Report:
*
The Acne market size is anticipated to grow with a significant CAGR during the study period (2019-2032)
*
In March 2025, Sagimet Biosciences Inc. (Nasdaq: SGMT), a clinical-stage biopharmaceutical company focused on developing novel therapies for metabolic and fibrotic disorders, announced that its Investigational New Drug (IND) application for TVB-3567 has been cleared. TVB-3567, a potent and selective fatty acid synthase (FASN) inhibitor, is set to enter clinical development for acne treatment. The U.S. Food and Drug Administration's Division of Dermatology and Dentistry has approved the IND, enabling the company to launch a first-in-human Phase 1 clinical trial in 2025.
*
In December 2024, Dermata Therapeutics, Inc. (NASDAQ: DRMA, DRMAW), a late-stage biotechnology company specializing in medical and aesthetic skin conditions, has announced the successful completion of patient enrollment in its pivotal Phase 3 Spongilla Treatment for Acne Research (STAR-1) study for DMT310. This once-weekly topical treatment is being developed for moderate-to-severe acne. STAR-1 is the first of two Phase 3 trials, and if results are positive, they will support Dermata's submission of a New Drug Application (NDA) for DMT310.
*
Key Acne Companies: BioPharmX, Bausch Health Americas, Inc., Kintor Pharma, Sol-Gel Technologies, Ltd., Ascletis Pharma, Galderma R&D, Torrent Pharma, Dermata Therapeutics, Clinuvel Pharma, Novan, Inc., Dermata Therapeutics, Accelovance, Balmoral Medical, Vyne Therapeutics Inc., XOMA (US) LLC, Braintree Laboratories, Teva Pharma, AnaptysBio, Inc., Janssen Research, Cutia Therapeutics, Bausch Health, and others
*
Key Acne Therapies: BPX-01, IDP-120, GT20029, KX-826, S6G5T-3, ASC40, GK530G, Dapsone, DMT310, CD5789 (trifarotene), Afamelanotide, NVN1000, Hydrogen Peroxide, Trifarotene Cream, S6G5T-3, GDC 268 Lotion, Isotretinoin, gevokizumab, BLI1100, AKLIEF Registered , Imsidolimab, RA-18C3, FMX101, IDP-126, and others
*
The Acne epidemiology based on gender analyzed that females are predominantly affected compared to males
*
The Acne market is expected to surge due to the disease's increasing prevalence and awareness during the forecast period. Furthermore, launching various multiple-stage Acne pipeline products will significantly revolutionize the Acne market dynamics.
Acne Overview
Acne is a common skin condition that occurs when hair follicles become clogged with oil (sebum), dead skin cells, and bacteria. It typically appears as pimples, blackheads, whiteheads, nodules, or cysts, mainly on the face, chest, back, and shoulders.
Acne is often linked to hormonal changes, genetics, stress, diet, and certain medications. While it is most common during adolescence, it can also affect adults. Treatment options include topical creams, oral medications, lifestyle changes, and professional procedures like laser therapy or chemical peels.
Get a Free sample for the Acne Market Report:
https://www.delveinsight.com/report-store/acne-market [https://www.delveinsight.com/report-store/acne-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=gpr]
Acne Epidemiology
The epidemiology section provides insights into the historical, current, and forecasted epidemiology trends in the seven major countries (7MM) from 2019 to 2032. It helps to recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. The epidemiology section also provides a detailed analysis of the diagnosed patient pool and future trends.
Acne Epidemiology Segmentation:
The Acne market report proffers epidemiological analysis for the study period 2024-2034 in the 7MM segmented into:
*
Total Prevalence of Acne
*
Prevalent Cases of Acne by severity
*
Gender-specific Prevalence of Acne
*
Diagnosed Cases of Episodic and Chronic Acne
Download the report to understand which factors are driving Acne epidemiology trends @ Acne Epidemiology Forecast [https://www.delveinsight.com/sample-request/acne-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=gpr]
Acne Drugs Uptake and Pipeline Development Activities
The drugs uptake section focuses on the rate of uptake of the potential drugs recently launched in the Acne market or expected to get launched during the study period. The analysis covers Acne market uptake by drugs, patient uptake by therapies, and sales of each drug.
Moreover, the therapeutics assessment section helps understand the drugs with the most rapid uptake and the reasons behind the maximal use of the drugs. Additionally, it compares the drugs based on market share.
The report also covers the Acne Pipeline Development Activities. It provides valuable insights about different therapeutic candidates in various stages and the key companies involved in developing targeted therapeutics. It also analyzes recent developments such as collaborations, acquisitions, mergers, licensing patent details, and other information for emerging therapies.
Acne Therapies and Key Companies
*
BPX-01: BioPharmX
*
IDP-120: Bausch Health Americas, Inc.
*
GT20029: Kintor Pharma
*
KX-826: KintorPharma
*
S6G5T-3: Sol-Gel Technologies, Ltd.
*
ASC40: Ascletis Pharma
*
GK530G: Galderma R&D
*
Dapsone: Torrent Pharma
*
DMT310: Dermata Therapeutics
*
CD5789 (trifarotene): Galderma R&D
*
Afamelanotide: Clinuvel Pharma
*
NVN1000: Novan, Inc.
*
Hydrogen Peroxide: Dermata Therapeutics
*
Trifarotene Cream: Galderma R&D
*
S6G5T-3: Accelovance
*
GDC 268 Lotion: Balmoral Medical
*
Isotretinoin: Vyne Therapeutics Inc.
*
gevokizumab: XOMA (US) LLC
*
BLI1100: Braintree Laboratories
*
AKLIEF Registered : Teva Pharma
*
Imsidolimab: AnaptysBio, Inc.
*
RA-18C3: Janssen Research
*
FMX101: Cutia Therapeutics
*
IDP-126: Bausch Health
Discover more about therapies set to grab major Acne market share @ Acne Treatment Market [https://www.delveinsight.com/sample-request/acne-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=gpr]
Scope of the Acne Market Report
*
Study Period: 2019-2032
*
Coverage: 7MM [The United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan]
*
Key Acne Companies: BioPharmX, Bausch Health Americas, Inc., Kintor Pharma, Sol-Gel Technologies, Ltd., Ascletis Pharma, Galderma R&D, Torrent Pharma, Dermata Therapeutics, Clinuvel Pharma, Novan, Inc., Dermata Therapeutics, Accelovance, Balmoral Medical, Vyne Therapeutics Inc., XOMA (US) LLC, Braintree Laboratories, Teva Pharma, AnaptysBio, Inc., Janssen Research, Cutia Therapeutics, Bausch Health, and others
*
Key Acne Therapies: BPX-01, IDP-120, GT20029, KX-826, S6G5T-3, ASC40, GK530G, Dapsone, DMT310, CD5789 (trifarotene), Afamelanotide, NVN1000, Hydrogen Peroxide, Trifarotene Cream, S6G5T-3, GDC 268 Lotion, Isotretinoin, gevokizumab, BLI1100, AKLIEF Registered , Imsidolimab, RA-18C3, FMX101, IDP-126, and others
*
Acne Therapeutic Assessment: Acne current marketed and Acne emerging therapies
*
Acne Market Dynamics: Acne market drivers and Acne market barriers
*
Competitive Intelligence Analysis: SWOT analysis, PESTLE analysis, Porter's five forces, BCG Matrix, Market entry strategies
*
Acne Unmet Needs, KOL's views, Analyst's views, Acne Market Access and Reimbursement
To know more about Acne companies working in the treatment market, visit @ Acne Clinical Trials and Therapeutic Assessment [https://www.delveinsight.com/sample-request/acne-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=gpr]
Table of Contents
1. Acne Market Report Introduction
2. Executive Summary for Acne
3. SWOT analysis of Acne
4. Acne Patient Share (%) Overview at a Glance
5. Acne Market Overview at a Glance
6. Acne Disease Background and Overview
7. Acne Epidemiology and Patient Population
8. Country-Specific Patient Population of Acne
9. Acne Current Treatment and Medical Practices
10. Acne Unmet Needs
11. Acne Emerging Therapies
12. Acne Market Outlook
13. Country-Wise Acne Market Analysis (2019-2032)
14. Acne Market Access and Reimbursement of Therapies
15. Acne Market Drivers
16. Acne Market Barriers
17. Acne Appendix
18. Acne Report Methodology
19. DelveInsight Capabilities
20. Disclaimer
21. About DelveInsight
About DelveInsight
DelveInsight is a leading Healthcare Business Consultant, and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance.
It also offers Healthcare Consulting Services, which benefits in market analysis to accelerate the business growth and overcome challenges with a practical approach.
Media Contact
Company Name: DelveInsight
Contact Person: Gaurav Bora
Email:Send Email [https://www.abnewswire.com/email_contact_us.php?pr=acne-market-on-track-for-major-expansion-by-2032-according-to-delveinsight-clinuvel-pharma-novan-dermata-therapeutics-iopharmx-bausch-health-americas-inc-kintor-pharma-solgel-technologies]
Phone: +14699457679
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: NV
Country: United States
Website: https://www.delveinsight.com/
Legal Disclaimer: Information contained on this page is provided by an independent third-party content provider. ABNewswire makes no warranties or responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you are affiliated with this article or have any complaints or copyright issues related to this article and would like it to be removed, please contact retract@swscontact.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Acne Market on Track for Major Expansion by 2032, According to DelveInsight | Clinuvel Pharma, Novan, Dermata Therapeutics, ioPharmX, Bausch Health Americas, Inc., Kintor Pharma, Sol-Gel Technologies here
News-ID: 3913141 • Views: …
More Releases from ABNewswire
Chondrosarcoma Pipeline Outlook Report 2025: MOA, Companies, Companies, Clinical …
DelveInsight's "Chondrosarcoma Pipeline Insight 2025" report provides comprehensive insights about 15+ companies and 15+ pipeline drugs in the Chondrosarcoma pipeline landscape. It covers the Chondrosarcoma pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Chondrosarcoma pipeline therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive Chondrosarcoma pipeline products in this space.
Explore our latest breakthroughs in Chondrosarcoma Research. Learn…
Maritime & Healthcare Group Announces Webinar: "From Policy to Practice: Women's …
Free Virtual Event on 27 November to Address Critical Gender Equality and Support Systems in the Maritime Industry
BERLIN, Germany, 19 November 2025 - Maritime & Healthcare Group (MHG), a leading organization dedicated to seafarer wellbeing, will host a landmark webinar on 27 November 2025, at 15:00 CET, titled "From Policy to Practice: Women's Wellbeing in Maritime."
The event, hosted by Maritime & Healthcare Group's Director of Mental Health Sofia Rizou, will…
Protect Business Profits: The Smart Way to Choose a Display Supermarket Refriger …
For any supermarket, the quality and safety of your chilled products are non-negotiable. Our Display Supermarket Refrigerator [https://www.runtecool.com/commercial-supermarket-display-refrigerator/] is engineered to meet the highest standards of food preservation, ensuring every item you sell is as fresh as the moment it was stocked. The advanced refrigeration system provides stable, even cooling that is absolutely essential for maintaining the integrity of everything from dairy to fresh-cut produce.
Image: https://www.runtecool.com/uploads/%E5%B2%9B%E6%9F%9C-1.jpg
*
Precision Temperature Control:
A powerful cooling…
Spitfire Nutrition's Flight Pre-Workout Gains National Attention for Its Bold Br …
Spitfire Nutrition, a growing Canadian brand, is earning national recognition for Flight, its standout pre-workout product praised by independent reviewers for its strong brand presence, memorable flavour experience, and customer appeal. The company's rapid rise reflects a commitment to transparency, third-party quality verification, and a customer-first approach that resonates with Canada's fitness community.
Spitfire Nutrition is emerging as one of Canada's most talked-about new brands, with independent third-party reviewers highlighting its…
More Releases for Acne
Expanding Acne Rates Support Global Anti-Acne Dermal Patch Market Expansion
As per a new market research report launched by Inkwood Research, the Global Anti-Acne Dermal Patch Market is expected to reach $971.37 million by 2032, projecting a CAGR of 7.32% during the forecast period, 2023-2032.
Refer to the Report Summary Here: https://inkwoodresearch.com/reports/anti-acne-dermal-patch-market/?utm_source=PaidPRNew&utm_medium=OpenPR&utm_campaign=InkwoodPR
This insightful market research report by Inkwood Research focuses on market trends, leading players, supply chain trends, technological innovations, key developments, and future strategies. The report covers all the…
Expanding Acne Rates Support Global Anti-Acne Dermal Patch Market Expansion
As per a new market research report launched by Inkwood Research, the Global Anti-Acne Dermal Patch Market is expected to reach $971.37 million by 2032, projecting a CAGR of 7.32% during 2023-2032.
Refer to the Report Summary Here: https://inkwoodresearch.com/reports/anti-acne-dermal-patch-market/?utm_source=PaidPRNew&utm_medium=OpenPR&utm_campaign=InkwoodPR
This insightful market research report by Inkwood Research focuses on market trends, leading players, supply chain trends, technological innovations, key developments, and future strategies. The report covers all the aspects of this comprehensive…
Growing Acne Incidences Benefiting Global Anti-Acne Dermal Patch Market Developm …
As per a new market research report launched by Inkwood Research, the Global Anti-Acne Dermal Patch Market is expected to reach $971.37 million by 2032, projecting a CAGR of 7.32% during 2023-2032.
Refer to the Report Summary Here: https://inkwoodresearch.com/reports/anti-acne-dermal-patch-market/?utm_source=PaidPRNew&utm_medium=OpenPR&utm_campaign=InkwoodPR
This insightful market research report by Inkwood Research focuses on market trends, leading players, supply chain trends, technological innovations, key developments, and future strategies. The report covers all the aspects of this comprehensive…
Expanding Acne Rates Support Global Anti-Acne Dermal Patch Market Expansion
As per a new market research report launched by Inkwood Research, the Global Anti-Acne Dermal Patch Market is expected to reach $971.37 million by 2032, projecting a CAGR of 7.32% during 2023-2032.
Refer to the Report Summary Here: https://inkwoodresearch.com/reports/anti-acne-dermal-patch-market/?utm_source=PaidPRNew&utm_medium=OpenPR&utm_campaign=InkwoodPR
This insightful market research report by Inkwood Research focuses on market trends, leading players, supply chain trends, technological innovations, key developments, and future strategies. The report covers all the aspects of…
Rising Cases of Acne Boosting Professional Acne Treatment Market Growth
Factor such as the rising cases of acne, surging adoption of acne treatments, growing healthcare spending, increasing disposable income, sedentary lifestyle, strong product pipeline, and mounting number of research programs are expected to propel the professional acne treatment market at a CAGR of 7.6% during 2020–2030. According to P&S Intelligence, the market size is expected to reach $13,124.5 million by 2030 from $6,298.9 million in 2020. Moreover, the market is…
Global Market Study on Acne Treatment Inflammatory Acne Segment Anticipated.
The global acne treatment market is stagnant in terms of incremental innovation as most players are investing in product reformulation instead of new product development. The analysts of Persistence Market Research have come up with a new publication titled “Acne Treatment Market: Global Industry Analysis and Forecast, 2017 – 2025,” and have observed that the North America region is expected to witness significant growth in market revenue due to rising affinity…
